New hope for adult leukemia patients: Triple-Threat treatment trial
NCT ID NCT07495631
Summary
This study tests a combination treatment approach for adults with newly diagnosed acute lymphoblastic leukemia (ALL). Researchers will combine a chemotherapy regimen designed for children with two additional treatments: a targeted drug called venetoclax and immunotherapy. The goal is to improve survival and disease control for adult patients, who typically have worse outcomes than children with the same disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.